Independent fund research. Built on SEC filings.

How we research funds

ETF · Alternatives · Agf Investments

AGF U.S. Market Neutral Anti-Beta Fund (BTAL)

Ticker BTAL · Since 2011-09-12 · · Holdings as of Jun 30, 2026

Expense ratio
1.25%$125/yr per $10k
5-yr return
−3.1%annualized
1-yr return
−20.6%as of Dec 2025
Net assets
$282.9Mall share classes
Holdings
405

Bottom line

Is BTAL a good fund? The bottom line

BTAL is a managed alternatives ETF from Agf Investments.

Annual fees run 1.25% — about $125 a year on every $10,000 invested, cheaper than 65% of alternatives funds we track.

It returned −20.6% over one year, −3.1% a year over five years, −2.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $283 million in net assets and 405 holdings, its largest position is Okta, Inc. (0.6%) and the top 10 make up 5.1% of the portfolio.

What stands out

  • Broadly diversified (405 holdings)

What to watch

  • 5-year return in the bottom quarter of its category
  • High turnover (295% a year) can mean more taxable distributions

Updated Nov 19, 2026

What BTAL invests in

The Fund seeks to provide a consistent negative beta exposure to the U.S. equity market.

In seeking to achieve its investment objective, the Fund will invest primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors. Based on mathematical assumptions derived from the long-term historical performance of the market, the Fund will construct a dollar neutral portfolio of long and short positions of U.S. equities by investing primarily in the constituent securities of the Dow Jones U.S. Thematic Market Neutral Low Beta Index (the Index) in approximately the same weight as they appear in the Index, subject to certain rules-based adjustments described below. The Fund is an actively-managed exchange-traded fund (ETF). Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in long and short equity securities of U.S.…

From the fund's prospectus (filed Oct 27, 2026).

BTAL performance

Fund calendar-year total returns, 2015–2025 2015: +3.2%; 2016: −4.7%; 2017: −2.8%; 2018: +15.0%; 2019: +1.7%; 2020: −13.8%; 2021: −7.3%; 2022: +20.9%; 2023: −14.9%; 2024: +13.0%; 2025: −20.6% +3% 2015 −5% 2016 −3% 2017 +15% 2018 +2% 2019 −14% 2020 −7% 2021 +21% 2022 −15% 2023 +13% 2024 −21% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
BTAL−20.6%−3.1%−2.2%
Alternatives median+7.4%+4.2%+3.8%

Source: Fund prospectus, as of Dec 31, 2025

Full BTAL performance history →

What BTAL costs

On a $10,000 investment, BTAL's 1.25% expense ratio costs about $125 a year. The prospectus estimates $1,748 in total costs over 10 years (assuming 5% annual returns). The median alternatives fund charges 1.54%.

See the full BTAL fee table →

BTAL top 10 holdings

#Holding% of fund
1Okta, Inc.0.63%
2Molina Healthcare, Inc.0.53%
3Rivian Automotive, Inc.0.51%
4Cardinal Health, Inc.0.51%
5AbbVie, Inc.0.50%
6Simpson Manufacturing Co., Inc.0.49%
7Cloudflare, Inc.0.48%
8DaVita, Inc.0.48%
9Lucid Group, Inc.0.48%
10Teledyne Technologies, Inc.0.48%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 5.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to BTAL

More funds like BTAL →

BTAL FAQ

What is the expense ratio of BTAL?
BTAL's expense ratio is 1.25%, which works out to about $125 a year for every $10,000 invested. The prospectus estimates total costs of $1,748 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BTAL a good investment?
It depends on your goals, but the data points to: broadly diversified (405 holdings); 5-year return in the bottom quarter of its category; high turnover (295% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does BTAL hold?
BTAL's largest holdings are Okta, Inc. (0.6%), Molina Healthcare, Inc. (0.5%), Rivian Automotive, Inc. (0.5%), Cardinal Health, Inc. (0.5%), AbbVie, Inc. (0.5%). It holds 405 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is BTAL's 5-year return?
BTAL returned −3.1% a year over the five years ending Dec 31, 2025, and −2.2% a year over ten years. Past performance does not guarantee future results.
Who manages BTAL?
BTAL is offered by Agf Investments through AGF Investments Trust.